Myosin

Myosin is a fundamental motor protein that plays a vital role in muscle contraction, intracellular transport, and various cellular movements. It interacts with actin filaments and uses energy derived from ATP hydrolysis to generate mechanical force. Understanding its structure and function provides key insights into the mechanisms of muscle physiology and the molecular basis of many diseases.

Introduction

Myosin is a superfamily of motor proteins responsible for converting chemical energy from adenosine triphosphate (ATP) into mechanical energy. This energy conversion drives numerous biological processes, including muscle contraction, organelle transport, cell division, and intracellular trafficking. It is one of the most studied proteins in biochemistry and physiology due to its critical role in both muscular and non-muscular systems.

First discovered in 1864 by Wilhelm Kühne while studying skeletal muscle extracts, myosin has since been classified into multiple isoforms found throughout different tissues and cell types. Its ability to interact with actin filaments forms the basis of the sliding filament theory, which explains how muscles shorten and produce force. Beyond muscle function, myosin’s action in non-muscle cells contributes to cell motility, cytokinesis, and maintenance of cell shape.

• Definition: Myosin is a contractile motor protein that interacts with actin to generate mechanical force through ATP hydrolysis.
• Importance: It is essential for muscle contraction, intracellular transport, and various cellular mechanical processes.
• Clinical Relevance: Mutations in myosin genes are linked to disorders such as cardiomyopathies, hearing loss, and certain congenital myopathies.

Structure of Myosin

General Molecular Architecture

The myosin molecule is a complex protein composed of multiple subunits that together perform coordinated mechanical functions. Each myosin molecule consists of two heavy chains and several light chains that form three main structural regions: the head, neck, and tail domains. These regions determine the molecule’s enzymatic activity, flexibility, and attachment to other cellular structures.

• Head Domain: The globular head contains both the ATP-binding site and the actin-binding site. It is responsible for the generation of force through ATP hydrolysis and interaction with actin filaments.
• Neck Domain: Acts as a lever arm that amplifies small conformational changes in the head during movement. It binds to light chains that stabilize the structure and regulate activity.
• Tail Domain: Determines the specific cellular role of the myosin molecule. It allows attachment to other myosin molecules, membranes, or cargo structures, depending on the isoform.

The myosin head region is often referred to as the “motor domain” because it performs the energy conversion necessary for movement. The coordinated rotation of this domain is what drives the power stroke that moves actin filaments relative to myosin filaments in muscle cells.

Isoforms and Variants

Myosin exists in a large superfamily of related proteins, each adapted to perform specific functions. These isoforms vary in molecular size, kinetic properties, and tissue distribution. Over 35 classes of myosin have been identified in eukaryotic organisms, though only a few are present in humans.

• Myosin I: A single-headed myosin found in non-muscle cells involved in membrane trafficking and endocytosis.
• Myosin II: The conventional double-headed myosin found in skeletal, cardiac, and smooth muscle. It is responsible for generating the contractile force in muscle tissue.
• Myosin V: A processive motor protein that transports vesicles and organelles along actin filaments within cells.
• Other Specialized Myosins: Myosin VI, VII, and XV have specialized roles in sensory cells, vesicle transport, and cellular architecture maintenance.

These isoforms exhibit structural conservation in the head region but differ significantly in their tail domains, which confer specificity to their cellular functions. The diversity of myosin variants ensures that the protein family can support a wide range of cellular and physiological processes.

Classification of Myosin

Based on Function and Localization

Myosins are classified according to their structural characteristics, cellular localization, and functional roles. The primary division separates conventional myosins, which are mainly involved in muscle contraction, from unconventional myosins that serve diverse roles in non-muscle cells, such as intracellular transport and cytoskeletal organization.

• Conventional (Class II) Myosins: These are the most studied myosins, found predominantly in skeletal, cardiac, and smooth muscles. They form thick filaments and generate force for muscle contraction by interacting with actin filaments. Each molecule consists of two heavy chains and four light chains organized into bipolar filaments that slide actin filaments past one another.
• Unconventional Myosins: Found in a wide range of tissues, unconventional myosins do not form large filaments. Instead, they function as individual molecules or dimers, transporting cellular cargo and contributing to cell shape changes, organelle movement, and membrane dynamics. Examples include myosin I, V, VI, and VII.

This classification highlights the versatility of the myosin superfamily in performing both contractile and non-contractile roles across different cell types.

Based on Tissue Distribution

Myosin expression varies depending on the tissue type and physiological function. Each muscle type possesses a distinct form of myosin adapted for its specific contraction requirements, while non-muscle myosins are found in virtually all cell types to support essential intracellular processes.

• Skeletal Muscle Myosin: The primary isoform in voluntary muscles, responsible for fast, forceful contractions. It is composed mainly of myosin II molecules arranged in sarcomeres, providing the mechanical basis for movement.
• Cardiac Muscle Myosin: Found in the heart, this myosin type enables rhythmic and continuous contractions. It exhibits specific kinetic properties that balance force generation and endurance to maintain cardiac function.
• Smooth Muscle Myosin: Present in the walls of hollow organs such as blood vessels and the digestive tract. It functions under the regulation of myosin light chain phosphorylation, allowing sustained contractions and tone maintenance.
• Non-Muscle Myosin: Found in nearly all cell types, these myosins are involved in cell division, motility, vesicle transport, and cytoskeletal remodeling. Their activity is crucial for processes such as cytokinesis and intracellular trafficking.

Although structurally related, each myosin type is optimized for its physiological environment, reflecting the adaptability of the protein’s molecular design.

Biochemical Properties

Myosin’s biochemical characteristics define its ability to convert chemical energy into mechanical work. These properties are determined by its ATPase activity, actin-binding capability, and regulatory mechanisms that control the kinetics of the cross-bridge cycle. Understanding these biochemical principles is essential to explain how myosin drives movement within cells and tissues.

• ATPase Activity and Energy Conversion: Myosin acts as an ATPase enzyme, hydrolyzing ATP to ADP and inorganic phosphate. The energy released from this reaction fuels the conformational changes that produce mechanical motion during muscle contraction or intracellular transport.
• Interaction with Actin Filaments: The head domain of myosin binds to specific sites on actin filaments, forming a reversible cross-bridge. This interaction is the basis of the sliding filament mechanism that shortens muscle fibers and generates tension.
• Phosphorylation and Regulation: The activity of certain myosins, particularly in smooth muscle and non-muscle cells, is modulated by phosphorylation of the myosin light chain. This process is mediated by myosin light chain kinase (MLCK) and regulated by calcium-calmodulin signaling.
• Cross-Bridge Cycling and Power Stroke: During contraction, myosin heads repeatedly attach to and detach from actin filaments in a cycle powered by ATP hydrolysis. Each cycle produces a “power stroke,” which moves the actin filament relative to the myosin filament, generating force and movement.

These biochemical features enable myosin to function as an efficient molecular motor capable of producing controlled and repetitive movements at both microscopic and macroscopic levels. The coordinated action of billions of myosin molecules underlies the contraction of entire muscles and the intracellular transport of organelles.

Mechanism of Action

Sliding Filament Theory

The sliding filament theory explains how myosin and actin filaments interact to produce muscle contraction. According to this model, muscle shortening occurs when myosin heads attach to actin filaments and pull them toward the center of the sarcomere, the basic contractile unit of muscle. The myosin filaments remain stationary, while actin filaments slide past them, leading to overall fiber shortening without a change in filament length.

Each myosin head functions as an independent force generator, undergoing repeated cycles of binding, pivoting, and detachment from actin. This collective action results in the shortening of sarcomeres, producing visible muscle contraction. The cycle is powered by the hydrolysis of ATP, which supplies the energy required for cross-bridge movement.

• Role of Myosin in Sarcomere Shortening: Myosin heads bind to actin at specific sites and pull the thin filaments toward the M-line, narrowing the I-band and H-zone.
• Energy Source: ATP provides the necessary energy for detachment and reattachment of myosin heads during successive contraction cycles.
• Calcium Regulation: In skeletal and cardiac muscle, calcium ions bind to troponin, causing tropomyosin to move and expose actin’s binding sites for myosin interaction.

Steps of Myosin–Actin Interaction

The molecular interaction between myosin and actin involves a sequence of coordinated biochemical events known as the cross-bridge cycle. Each step is dependent on the binding and hydrolysis of ATP, as well as conformational changes in the myosin head.

1. ATP Binding: A new ATP molecule binds to the myosin head, causing it to detach from the actin filament, breaking the existing cross-bridge.
2. ATP Hydrolysis: Myosin hydrolyzes ATP into ADP and inorganic phosphate (Pi), which energizes the head and causes it to enter a “cocked” position.
3. Cross-Bridge Formation: The energized myosin head binds to a new site on the actin filament, forming a cross-bridge.
4. Power Stroke: Release of inorganic phosphate triggers the power stroke, where the myosin head pivots, pulling the actin filament toward the center of the sarcomere.
5. ADP Release and Resetting: ADP is released after the power stroke, and the myosin head remains attached until another ATP molecule binds, restarting the cycle.

This continuous process occurs billions of times across muscle fibers during contraction, producing smooth and coordinated movement. The speed and strength of contraction depend on the type of myosin isoform and its ATPase activity.

Types of Myosin in the Human Body

Muscle Myosins

Muscle myosins belong primarily to class II and are responsible for generating the mechanical force required for muscle contraction. Each muscle type expresses specific myosin isoforms adapted for its functional needs, such as speed, strength, and endurance.

• Myosin II in Skeletal and Cardiac Muscle: Composed of two heavy chains and two pairs of light chains, this isoform forms thick filaments within sarcomeres. In skeletal muscle, it enables rapid and forceful contractions, while in cardiac muscle, it supports rhythmic and sustained contractions essential for pumping blood.
• Myosin in Smooth Muscle: Smooth muscle myosin is structurally similar to skeletal muscle myosin but differs in its regulation. It requires phosphorylation of the regulatory light chain by myosin light chain kinase (MLCK) for activation, allowing slower and sustained contractions important for controlling organ tone and vessel diameter.

Non-Muscle Myosins

Non-muscle myosins perform essential roles in cell shape maintenance, intracellular trafficking, and division. These myosins do not assemble into large filaments like muscle myosins but function as single molecules or small clusters to move cargo or contract cellular structures.

• Myosin I: A monomeric myosin involved in membrane trafficking, endocytosis, and maintaining cortical tension near the plasma membrane.
• Myosin V: A dimeric, processive motor protein that transports vesicles, organelles, and melanosomes along actin filaments in neurons and secretory cells.
• Myosin VI and VII: These specialized myosins move toward the minus end of actin filaments, playing roles in intracellular transport, sensory functions, and auditory mechanisms within hair cells of the inner ear.

Together, these myosin classes ensure the efficient operation of muscular and non-muscular systems, providing both contractile force and intracellular motility across diverse biological contexts.

Regulation of Myosin Activity

The activity of myosin is tightly regulated to ensure precise control of muscle contraction and cellular motility. This regulation involves complex biochemical pathways and molecular interactions that modulate the binding affinity of myosin for actin, its ATPase activity, and its structural conformation. Regulation occurs differently in various tissues, reflecting the specialized roles of myosin in muscle and non-muscle cells.

• Role of Calcium Ions and Calmodulin: Calcium serves as a critical regulator of myosin activation. In muscle cells, an increase in intracellular calcium levels triggers contraction. In smooth muscle, calcium binds to calmodulin, forming a complex that activates myosin light chain kinase (MLCK), which phosphorylates the myosin light chain and initiates the cross-bridge cycle.
• Myosin Light Chain Kinase (MLCK) and Phosphorylation Control: MLCK catalyzes the phosphorylation of the regulatory light chain on myosin, enhancing its ATPase activity and promoting interaction with actin. Dephosphorylation by myosin light chain phosphatase (MLCP) leads to relaxation by reducing myosin’s affinity for actin.
• Regulation by Tropomyosin and Troponin Complex: In striated muscle, contraction is regulated by the troponin–tropomyosin complex located on actin filaments. When calcium binds to troponin C, the complex undergoes a conformational change that exposes the myosin-binding sites on actin, allowing the formation of cross-bridges.
• Influence of ATP and Energy Availability: ATP concentration determines myosin’s ability to detach from actin and initiate new contraction cycles. Low ATP levels, as seen in rigor mortis, result in the formation of stable actin–myosin complexes, leading to muscle stiffness.

These regulatory mechanisms ensure that myosin activity is coordinated with cellular signaling pathways and energy metabolism, maintaining balance between contraction and relaxation. The precise control of myosin’s interaction with actin allows muscles to perform smooth, sustained, and graded contractions as required by physiological conditions.

Genetic and Molecular Aspects

The genes encoding myosin proteins belong to large gene families that produce a diverse array of isoforms adapted for specific cellular functions. Genetic variations within these families influence contractile properties, tissue-specific expression, and susceptibility to disease. Understanding the molecular genetics of myosin provides critical insight into hereditary muscle and cardiac disorders.

• Myosin Gene Families (MYH, MYL, MYO): Myosin heavy chain genes (MYH) encode the catalytic and structural domains responsible for force generation, while myosin light chain genes (MYL) encode regulatory subunits that modulate activity. The MYO family includes non-muscle myosins involved in intracellular transport and cell division.
• Gene Expression and Isoform Diversity: Different myosin isoforms are expressed according to tissue type and developmental stage. For example, MYH7 is predominantly expressed in cardiac and slow-twitch skeletal muscle, whereas MYH2 and MYH1 are associated with fast-twitch fibers. Alternative splicing of myosin genes further contributes to protein diversity.
• Mutations and Functional Consequences: Mutations in myosin genes can alter protein folding, ATPase kinetics, or actin-binding affinity. Such alterations disrupt muscle contraction or cellular motility, leading to clinical disorders such as hypertrophic cardiomyopathy, myosin storage myopathy, or sensorineural hearing loss.

Advances in molecular biology and genomics have enabled precise mapping of myosin gene mutations and their physiological effects. This has facilitated the development of targeted diagnostic tests and novel therapeutic interventions for myosin-related diseases, bridging the gap between molecular genetics and clinical practice.

Clinical Significance

Myosin-Related Disorders

Mutations or dysfunctions in myosin genes and proteins are associated with a range of human diseases that affect both muscle and non-muscle tissues. Because myosin plays a central role in contraction, movement, and intracellular transport, even minor alterations can produce significant pathological effects.

• Hypertrophic and Dilated Cardiomyopathy (MYH7 Mutations): Mutations in the MYH7 gene, which encodes the β-cardiac myosin heavy chain, lead to structural and functional abnormalities in cardiac muscle. Hypertrophic cardiomyopathy results in thickened ventricular walls and diastolic dysfunction, while dilated cardiomyopathy is characterized by weakened contractility and ventricular dilation.
• Myosin Storage Myopathy: A rare genetic disorder caused by mutations in the MYH7 gene, leading to accumulation of myosin in skeletal muscle fibers. Symptoms include muscle weakness, fatigue, and delayed motor development.
• Hearing Loss Due to MYO7A Mutations: Mutations in the MYO7A gene, which encodes unconventional myosin VIIA, cause defects in hair cell function within the inner ear. This results in sensorineural hearing loss and is associated with Usher syndrome type 1B.
• Neuromuscular and Cytoskeletal Disorders: Defective non-muscle myosins such as MYO5A and MYO6 can impair organelle transport and cell migration, contributing to neurological and developmental abnormalities.

These disorders illustrate the vital importance of myosin in maintaining normal muscle physiology and cellular homeostasis. Early diagnosis through genetic screening and molecular analysis has become a key component in managing these myosin-related diseases.

Diagnostic and Therapeutic Implications

Advances in diagnostic genetics and molecular medicine have improved the ability to detect and manage myosin-related conditions. Therapeutic research is focused on restoring normal protein function and compensating for the biochemical consequences of defective myosin activity.

• Genetic Testing for Myosin Mutations: Modern diagnostic tools, including next-generation sequencing, allow for precise identification of pathogenic variants in myosin genes. These tests help guide clinical decisions and enable family screening in hereditary myopathies and cardiomyopathies.
• Pharmacological Modulation of Myosin Activity: Drugs such as myosin activators and inhibitors are being developed to correct functional abnormalities. For instance, omecamtiv mecarbil enhances cardiac myosin ATPase activity and improves contractility in systolic heart failure, while mavacamten reduces hypercontractility in hypertrophic cardiomyopathy.
• Emerging Therapies: Gene therapy, RNA-based interventions, and targeted molecular chaperones represent promising approaches for future treatment. These therapies aim to correct or compensate for defective myosin synthesis and folding.

Ongoing research into myosin function and its molecular regulation continues to reveal new opportunities for diagnosis and treatment. Understanding the relationship between gene mutations and protein dysfunction is key to developing personalized therapies for myosin-associated diseases.

Research and Experimental Insights

Scientific studies of myosin have advanced significantly with the introduction of high-resolution imaging, molecular biology, and biophysical techniques. These approaches have deepened our understanding of myosin’s structure, mechanics, and its role in cellular physiology.

• Structural Studies Using Cryo-Electron Microscopy: Modern cryo-EM techniques have revealed detailed images of myosin in various conformational states, providing insight into how ATP hydrolysis drives structural transitions during the power stroke.
• Single Molecule Force Measurements: Optical tweezers and atomic force microscopy have allowed scientists to measure the forces generated by individual myosin molecules, quantifying their step size and energy efficiency in real time.
• Role of Myosin in Cell Migration and Intracellular Transport: Research on unconventional myosins has shown their critical functions in vesicle trafficking, organelle positioning, and cell motility, which are essential for processes such as wound healing and immune responses.
• Advances in Myosin Inhibitors and Activators: New compounds targeting specific myosin isoforms are being explored to modulate contractility in diseases like cardiac failure and hypertension. These pharmacological agents offer promising therapeutic potential.

Through continued experimental investigation, researchers are uncovering novel insights into the molecular mechanisms governing myosin activity. These discoveries not only expand basic biological understanding but also pave the way for clinical innovations that target myosin function at the molecular level.

References

1. Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 7th ed. Garland Science; 2022.
2. Cooper GM, Hausman RE. The Cell: A Molecular Approach. 9th ed. Oxford University Press; 2023.
3. Huxley HE. The double array of filaments in cross-striated muscle. J Biophys Biochem Cytol. 1957;3(5):631–648.
4. Spudich JA. The myosin swinging cross-bridge model. Nat Rev Mol Cell Biol. 2001;2(5):387–392.
5. Howard J. Mechanics of Motor Proteins and the Cytoskeleton. Sinauer Associates; 2001.
6. Geeves MA, Holmes KC. The molecular mechanism of muscle contraction. Adv Protein Chem. 2005;71:161–193.
7. Bloemink MJ, Geeves MA. Shaking the myosin family tree: biochemical kinetics defines four types of myosin motor. Semin Cell Dev Biol. 2011;22(9):961–967.
8. Rayment I, Holden HM, Whittaker M, et al. Structure of the actin–myosin complex and its implications for muscle contraction. Science. 1993;261(5117):58–65.
9. Harrington WF, Rodgers ME. Myosin. Annu Rev Biochem. 1984;53:35–73.
10. Greenberg MJ, Shuman H, Ostap EM. Inherent force-dependent properties of β-cardiac myosin contribute to the force-velocity relationship of cardiac muscle. Biophys J. 2014;107(12):L41–L44.